ClinConnect ClinConnect Logo
Search / Trial NCT06062394

Penn Medicine Healthy Heart

Launched by UNIVERSITY OF PENNSYLVANIA · Sep 25, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The Penn Medicine Healthy Heart trial is a study aimed at helping patients in West and Southwest Philadelphia and Lancaster improve their blood pressure and cholesterol levels. The trial will use tools and platforms to identify patients who might benefit from a program designed to encourage healthier behaviors over a period of six months. This is important because high blood pressure and cholesterol can lead to serious health issues, and the study hopes to find effective ways to support patients in managing these conditions.

To participate, you need to be a patient in the Penn Medicine Primary Care network and have had high blood pressure readings (140 or higher) in the last year, along with certain risk factors for heart disease or diabetes. You also need to be off certain cholesterol medications or on a low-intensity statin with high cholesterol levels. If you’re selected, you can expect support and guidance to help you make positive changes to your health. It’s worth noting that the study is currently recruiting participants, so if you or someone you know fits the criteria, this could be a great opportunity to improve heart health.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • On the Penn Medicine Primary Care Service Line registry
  • Last 2 Blood Pressure readings with Systolic Blood Pressure \>=140 from any outpatient encounter in the last 12 months AND
  • ASCVD dx OR ASCVD risk score ≥10% OR Diabetes dx OR A1c ≥6.5 in last year OR Diabetes registry OR Last LDL ≥190 in past five years AND
  • Not on a statinor PCSK9, Inclisiran OR on a Low-intensity/moderate-intensity statin) with LDL \>100
  • Exclusion Criteria:
  • Patients on PCSK9 inhibitors
  • Documented statin allergy/ or intolerance in the EMR
  • Pregnancy
  • Breast feeding
  • * Markedly shortened life expectancy including:
  • 1. metastatic cancer
  • 2. hospice
  • 3. End Stage Renal Disease
  • 4. Congestive Heart Failure
  • 5. Dementia
  • Is a non-English speaker requiring a translator
  • Patients who do not have a cell phone

About University Of Pennsylvania

The University of Pennsylvania, a prestigious Ivy League institution located in Philadelphia, is renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and cutting-edge facilities to conduct innovative studies across various therapeutic areas. With a focus on translating scientific discoveries into clinical applications, the University of Pennsylvania fosters collaborations among leading researchers, clinicians, and industry partners, ensuring rigorous trial design and adherence to ethical standards. Through its dedication to excellence in research and education, the university plays a pivotal role in shaping the future of medicine.

Locations

Philadelphia, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Kevin Volpp, MD, PhD

Principal Investigator

University of Pennsylvania

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported